0001179110-15-001899.txt : 20150204
0001179110-15-001899.hdr.sgml : 20150204
20150204205216
ACCESSION NUMBER: 0001179110-15-001899
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150202
FILED AS OF DATE: 20150204
DATE AS OF CHANGE: 20150204
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Washington Robin L
CENTRAL INDEX KEY: 0001327145
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 15577212
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
edgar.xml
FORM 4 -
X0306
4
2015-02-02
0
0000882095
GILEAD SCIENCES INC
GILD
0001327145
Washington Robin L
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
0
1
0
0
EVP, CFO
Common Stock
2015-02-02
4
M
0
11550
19.085
A
61382
D
Common Stock
2015-02-02
4
M
0
4800
23.755
A
66182
D
Common Stock
2015-02-02
4
M
0
11250
24.295
A
77432
D
Common Stock
2015-02-02
4
M
0
5592
40.56
A
83024
D
Common Stock
2015-02-02
4
S
0
24392
105.1379
D
58632
D
Common Stock
2015-02-02
4
S
0
8200
105.9789
D
50432
D
Common Stock
2015-02-02
4
S
0
600
106.8517
D
49832
D
Non-Qualified Stock Option (right to buy)
19.085
2015-02-02
4
M
0
11550
0
D
2021-01-20
Common Stock
11550
0
D
Non-Qualified Stock Option (right to buy)
23.755
2015-02-02
4
M
0
4800
0
D
2020-01-28
Common Stock
4800
0
D
Non-Qualified Stock Option (right to buy)
24.295
2015-02-02
4
M
0
11250
0
D
2022-01-26
Common Stock
11250
45000
D
Non-Qualified Stock Option (right to buy)
40.56
2015-02-02
4
M
0
5592
0
D
2023-02-01
Commmon Stock
5592
44750
D
The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Sale prices reported for the transactions reported here range from $104.63 to $105.62. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $105.64 to $106.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $106.71 to $107.07. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
/s/ John F. Milligan by Power of Attorney for Robin L. Washington
2015-02-04